[1] DR. GLORIA HERNáNDEZ-TORRES. A Reversible and Selective Inhibitor of Monoacylglycerol Lipase Ameliorates Multiple Sclerosis[J]. Angewandte Chemie International Edition, 2014, 53 50: 13765-13770. DOI:
10.1002/anie.201407807[2] JOHN D DOUGLASS. Global deletion of MGL in mice delays lipid absorption and alters energy homeostasis and diet-induced obesity.[J]. Journal of Lipid Research, 2015, 56 6: 1153-1171. DOI:
10.1194/jlr.m058586[3] CAROLINE MORIN Samuel F Pierre U Blier. Eicosapentaenoic acid and docosapentaenoic acid monoglycerides are more potent than docosahexaenoic acid monoglyceride to resolve inflammation in a rheumatoid arthritis model.[J]. Arthritis Research & Therapy, 2015: 142. DOI:
10.1186/s13075-015-0653-y[4] CAROLINE MORIN Samuel F éric Rousseau. Anti-proliferative effects of a new docosapentaenoic acid monoacylglyceride in colorectal carcinoma cells[J]. Prostaglandins, leukotrienes, and essential fatty acids, 2013, 89 4: Pages 203-213. DOI:
10.1016/j.plefa.2013.07.004[5] HUGO TREMBLAY . One-pot synthesis of polyunsaturated fatty acid amides with anti-proliferative properties[J]. Bioorganic & Medicinal Chemistry Letters, 2014, 24 24: Pages 5635-5638. DOI:
10.1016/j.bmcl.2014.10.084[6] MICHIEL G.J. BALVERS . Docosahexaenoic acid and eicosapentaenoic acid are converted by 3T3-L1 adipocytes to N-acyl ethanolamines with anti-inflammatory properties[J]. Biochimica et biophysica acta. Molecular and cell biology of lipids, 2010, 1801 10: Pages 1107-1114. DOI:
10.1016/j.bbalip.2010.06.006